Submission for OMB Review; 30-day Comment Request; A Generic Submission for Formative Research, Pre-Testing, Stakeholder Measures and Advocate Forms at NCI, 58363-58364 [2014-23081]
Download as PDF
<![CDATA[
58363
Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices
policy to remain dynamic and be
responsive to changing circumstances
that affect UIOs. It is expected that the
confer process may result in the need to
update the policy from time to time.
5–26.7 Deliberative Process Privilege
Nothing in this Policy waives the
Government’s deliberative process
privilege. Examples of the government’s
deliberative process privilege are as
follows:
(1) When the Secretary, HHS, is
specifically requested by a member or
members of Congress to respond to or
report on proposed legislation, the
development of such responses and of
related policy is a part of the Executive
Branch’s deliberative process privilege
and should remain confidential.
(2) In specified instances, when
Congress requires the HHS to work with
UIOs on the development of
recommendations that may require
legislation, such as reports,
recommendations, or other products
that are developed independent of a
Department position, the development
of which is governed by Office of
Management and Budget Circular A–19.
Dated: September 22, 2014.
Yvette Roubideaux,
Acting Director, Indian Health Service.
[FR Doc. 2014–23005 Filed 9–26–14; 8:45 am]
BILLING CODE 4160–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day
Comment Request; A Generic
Submission for Formative Research,
Pre-Testing, Stakeholder Measures
and Advocate Forms at NCI
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
SUMMARY:
NCI’s authorized programs. It is
beneficial for NCI, through the OAR, to
pretest strategies, concepts, activities
and materials while they are under
development. Additionally,
administrative forms are a necessary
part of collecting demographic
information and areas of interest for
advocates. Pre-testing, or formative
evaluation, helps ensure that the
products and services developed by NCI
have the greatest capacity of being
received, understood, and accepted by
their target audiences. Since OAR is
responsible for matching advocates to
NCI programs and initiatives across the
cancer continuum, it is necessary to
measure the satisfaction of both internal
and external stakeholders with this
collaboration. This customer satisfaction
research helps ensure the relevance,
utility, and appropriateness of the many
initiatives and products that OAR and
NCI produce. The OAR will use a
variety of qualitative (focus groups,
interviews) and quantitative (paper,
phone, in-person, and web surveys)
methodologies to conduct this research,
allowing NCI to: 1) Understand
characteristics (attitudes, beliefs, and
behaviors) of the intended target
audience and use this information in the
development of effective strategies,
concepts, activities; 2) use a feedback
loop to help refine, revise, and enhance
OAR’s efforts—ensuring that they have
the greatest relevance, utility,
appropriateness, and impact for/to
target audiences; and 3) expend limited
program resource dollars wisely and
effectively. The anticipated individual
respondents will consist of: Adult
cancer research advocates, members of
the public, health care professionals,
and organizational representatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,025.
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on July 18, 2014
(Volume 79, P. 42023) and allowed 60days for public comment. There were no
comments received.
Direct comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Kelley Landy, Acting Director
of the Office of Advocacy Relations
(OAR), NCI, NIH, 31 Center Drive, Bldg.
31, Room 10A28, MSC 2580, Bethesda,
MD 20892, call non-toll-free number
301–594–3194, or email your request,
including your address, to kelley.landy@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
Proposed Collection: A Generic
Submission for Formative Research, Pretesting, Stakeholder Measures and
Advocate Forms at NCI, 0925–0641,
Revision, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The Office of Advocacy
Relations (OAR) disseminates cancerrelated information to a variety of
stakeholders, seeks input and feedback,
and facilitates collaboration to advance
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Individuals .........................................
tkelley on DSK3SPTVN1PROD with NOTICES
Respondent type
Self-Administered Questionnaires ....
Individual In-Depth Interviews ..........
Focus Group Interviews ...................
VerDate Sep<11>2014
16:44 Sep 26, 2014
Jkt 232001
PO 00000
Frm 00051
Fmt 4703
Sfmt 9990
Frequency of
response
800
75
100
E:\FR\FM\29SEN1.SGM
1
1
1
29SEN1
Average time
per response
(minutes/hour)
Annual burden
hours
1
1
90/60
800
75
150
58364
Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices
Dated: September 23, 2014
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–23081 Filed 9–26–14; 8:45 am]
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
tkelley on DSK3SPTVN1PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Pilot Clinical Trials to
Eliminate the Latent HIV Reservoir (U01).
Date: November 24, 2014.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
4F100 Bldg. FL, 5601 Fisher Lane, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health/NIAID, 6700B Rockledge Drive, MSC
7616, Rm 3134, Bethesda, MD 20892, 301–
435–2766, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: September 23, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–23037 Filed 9–26–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:44 Sep 26, 2014
Jkt 232001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel NIAMS
Small Grant Program for New Investigators
(R03)
Date: October 22–23, 2014
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health One
Democracy Plaza 6701 Democracy Boulevard,
Suite 800 Bethesda, MD 20892 (Virtual
Meeting)
Contact Person: Xincheng Zheng, MD,
Ph.D. Scientific Review Officer Scientific
Review Branch National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–594–4953,
xincheng.zheng@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: September 23, 2014.
Carolyn Baum
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–23019 Filed 9–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: October 21–22, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vectors and Pathogens.
Date: October 22–23, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Fouad A El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Societal and Ethical Issues in Research Study
Section.
Date: October 22, 2014.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marines’ Memorial Club and Hotel,
609 Sutter Street, San Francisco, CA 94102.
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative Physiology of Obesity and
Diabetes Study Section.
Date: October 23–24, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Reed A Graves, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 79, Number 188 (Monday, September 29, 2014)]
[Notices]
[Pages 58363-58364]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23081]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day Comment Request; A Generic
Submission for Formative Research, Pre-Testing, Stakeholder Measures
and Advocate Forms at NCI
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH), has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on July 18, 2014 (Volume 79, P. 42023) and allowed 60-days for
public comment. There were no comments received.
Direct comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRAsubmission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project contact: Kelley Landy, Acting Director of the Office
of Advocacy Relations (OAR), NCI, NIH, 31 Center Drive, Bldg. 31, Room
10A28, MSC 2580, Bethesda, MD 20892, call non-toll-free number 301-594-
3194, or email your request, including your address, to
kelley.landy@nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Proposed Collection: A Generic Submission for Formative Research,
Pre-testing, Stakeholder Measures and Advocate Forms at NCI, 0925-0641,
Revision, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: The Office of Advocacy
Relations (OAR) disseminates cancer-related information to a variety of
stakeholders, seeks input and feedback, and facilitates collaboration
to advance NCI's authorized programs. It is beneficial for NCI, through
the OAR, to pretest strategies, concepts, activities and materials
while they are under development. Additionally, administrative forms
are a necessary part of collecting demographic information and areas of
interest for advocates. Pre-testing, or formative evaluation, helps
ensure that the products and services developed by NCI have the
greatest capacity of being received, understood, and accepted by their
target audiences. Since OAR is responsible for matching advocates to
NCI programs and initiatives across the cancer continuum, it is
necessary to measure the satisfaction of both internal and external
stakeholders with this collaboration. This customer satisfaction
research helps ensure the relevance, utility, and appropriateness of
the many initiatives and products that OAR and NCI produce. The OAR
will use a variety of qualitative (focus groups, interviews) and
quantitative (paper, phone, in-person, and web surveys) methodologies
to conduct this research, allowing NCI to: 1) Understand
characteristics (attitudes, beliefs, and behaviors) of the intended
target audience and use this information in the development of
effective strategies, concepts, activities; 2) use a feedback loop to
help refine, revise, and enhance OAR's efforts--ensuring that they have
the greatest relevance, utility, appropriateness, and impact for/to
target audiences; and 3) expend limited program resource dollars wisely
and effectively. The anticipated individual respondents will consist
of: Adult cancer research advocates, members of the public, health care
professionals, and organizational representatives.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1,025.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Respondent type Form name Number of Frequency of per response Annual burden
respondents response (minutes/hour) hours
----------------------------------------------------------------------------------------------------------------
Individuals................... Self- 800 1 1 800
Administered
Questionnaires.
Individual In- 75 1 1 75
Depth
Interviews.
Focus Group 100 1 90/60 150
Interviews.
----------------------------------------------------------------------------------------------------------------
[[Page 58364]]
Dated: September 23, 2014
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-23081 Filed 9-26-14; 8:45 am]
BILLING CODE 4140-01-P
